Fenticonazole Nitrate/Tinidazole/Lidocaine

硝酸芬替康唑/替硝唑/利多卡因

Report date: 2026/02/13 10:40:17

Base Information

Drug NameFenticonazole Nitrate/Tinidazole/Lidocaine
Drug Alias NameEVEGYN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionErgosterol biosynthesis inhibitorsDNA bindersSodium channel alpha subunit modulators
TargetsErgosterolDNASodium channel alpha subunit
Therapy Area/IndicationsVaginitisVaginal DiseasesTrichomonas Vaginitis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTurkey
CombinationsYes Fenticonazole NitrateTinidazoleLidocaine
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesExeltis Turkey
China Registration ClassN/A

Develop Information

Active CompaniesExeltis TurkeyEge University
Inactive CompaniesN/A
Active IndicationsVaginitisVaginal DiseasesTrichomonas Vaginitis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A